Triplet (FOLFOXIRI) Versus Doublet (FOLFOX or FOLFIRI) Regimen as First Line Treatment in Metastatic Colorectal Carcinoma, a Prospective Phase II, Randomized Controlled Trial

The outcomes of treatment of metastatic colorectal cancer (mCRC) is still unsatisfactory. Several trials approved that, the upfront treatment with triplet regimen included fluorouracil, leucovorin, irinotecan and oxaliplatin improved the outcomes of patients with metastatic disease as compared to st...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Asian Pacific Journal of Cancer Prevention 2022-10, Vol.23 (10), p.3421-3429
Hauptverfasser:	Khalil, Khaled Ahmed, Musallam, Hanan Selim, Hassan, Mohamed Abdulla, Mahmoud, Inas Abdou
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - adverse effects Bevacizumab Camptothecin Colorectal Neoplasms - pathology Fluorouracil Humans Leucovorin Prospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!